Comparison of the efficiency of two commercial kits – ELFA and Western blot in estimating the phase of Toxoplasma gondii infection in pregnant women
More details
Hide details
Department of Biological Health Hazards and Parasitology, Institute of Rural Health, Lublin, Poland
Department of Parasitology, National Veterinary Research Institute, Puławy, Poland
Department for Woman Health, Institute of Rural Health in Lublin, Poland
Ann Agric Environ Med. 2016;23(4):570-575
Sera of 89 pregnant women were selected according to the results of ELFA IgM, IgG and avidity IgG, and tested with commercial tests IgM, IgG and avidity IgG Western Blot (WB) to compare the efficacy of both techniques in determining the phase of T. gondii infection. In total, 81 of 89 tested sera (91.0%) were classified as positive, both in the ELFA and WB tests for the presence of anti-Toxoplasma antibodies of class IgG, indicating a past infection, while the prevalence of anti-Toxoplasma positive reactions associated with the antibodies of class IgM indicating a recent infection was much lower – 31.5% and 20.2%, respectively. Sera of 81 women were also tested in the ELFA and WB tests for avidity, e.g. ability of forming high-molecular IgG antibody complexes. Low or medium results in these tests (in this study all classified as low), indicating a recent infection, were detected by ELFA and WB in 22.2% and 45.7% of the total examined samples, respectively. The Spearman’s rank test for correlation, performed for recognition of quantitative data of the ELFA and WB tests (index, units or points), revealed a highly significant correlation between the ELFA and WB tests for homologous classes of antibodies, both for IgM and IgG (p<0.00001). In contrast, the ELFA and WB tests for detection of anti-Toxoplasma IgM antibodies were not correlated with the ELFA and WB tests for detection of anti-Toxoplasma IgG antibodies (p>0.05), except for the WB test for IgM antibodies, which showed a significant correlation with the ELFA test for IgG antibodies (p<0.01). A highly significant negative correlation between the ELFA and WB test for IgM antibodies and ELFA and WB tests for IgG avidity was demonstrated (p<0.01), except for a relationship between the WB test for IgM and WB for avidity, which was not significant. Such negative correlations are theoretically expected, as strong complexes with the participation of IgG antibodies are absent in the early phase of toxoplasmosis when early antibodies of IgM class are present. Summarizing, this study indicates the high usefulness of the commercial ELFA and WB tests in serodiagnostics of toxoplasmosis in pregnant women. Special attention should be paid to parallel detection of IgM antibodies and low values in the ELFA and WB tests for IgG avidity, which indicates a recent infection which may be associated with a clinical form of congenital toxoplasmosis and damage to the foetus.
Dubey J P, Jones J L. Toxoplasma gondii infection in humans and animals in the United States. Int J Parasitol. 2008; 38: 1257–1278.
Tenter A M, Heckeroth A R, Weiss L M. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000; 30: 1217–1258.
Montoya J G, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965–1976.
Paul M, Petersen E, Szczapa J. Prevalence of congenital Toxoplasma gondii infection among newborns from the Poznań region of Poland: validation of a new combined enzyme immunoassay for Toxoplasma gondii-specific immunoglobulin A and immunoglobulin M antibodies. J Clin Microbiol. 2001; 39: 1912–1916.
Paul M. Potential risk factors for Toxoplasma gondii infection in cases with recently acquired toxoplasmosis. Przegl Epidemiol. 1998; 52: 447–54.
Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002; 185 (Suppl. 1): S73-S82 doi:10.1086/338827.
Liesenfeld O, Press C, Montoya J G, Gill R, Isaac-Renton J L, Hedman K, Remington J S. False-positive results in immunoglobulin M (IgM) Toxoplasma antibody tests and importance of confirmatory testing: the Platelia toxo IgM test. J Clin Microbiol. 1997; 35: 174–178.
Lappalainen M, Hedman K. Serodiagnosis of toxoplasmosis. The impact of measurement of IgG avidity. Ann Ist Super Sanita. 2004; 40: 81–88.
Liesenfeld O, Montoya J G, Kinney S, Press C, Remington J S. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis. 2001; 183: 1248–53.
Holec-Gąsior L. Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis–the current status of studies. Clin Vaccine Immunol. 2013; 20: 1343–1351.
Pfrepper K, Enders G, Gohl M, Krczal D, Hlobil H, Wassenberg D, Soutschek E. Seroreactivity to and avidity for recombinant antigens in toxoplasmosis. Clin Diagn Lab Immunol. 2005; 12: 977–82.
Journals System - logo
Scroll to top